His primary areas of study are Cell biology, Cathelicidin, Innate immune system, Antimicrobial peptides and Microbiology. His Cell biology research is multidisciplinary, relying on both Mast cell, Inflammation, Proinflammatory cytokine and Bone marrow. His Cathelicidin study combines topics in areas such as Rectum, Adverse effect and Saline.
His study looks at the intersection of Innate immune system and topics like MAPK/ERK pathway with Reactive oxygen species. Isao Nagaoka interconnects Chemokine, Secretion and Cytokine in the investigation of issues within Antimicrobial peptides. His studies deal with areas such as Antibacterial activity, Escherichia coli and Staphylococcus aureus as well as Microbiology.
His primary scientific interests are in Internal medicine, Biochemistry, Molecular biology, Cell biology and Endocrinology. His research investigates the link between Molecular biology and topics such as Messenger RNA that cross with problems in Growth factor and Platelet-derived growth factor receptor. His work carried out in the field of Cell biology brings together such families of science as Inflammation, Apoptosis, Cathelicidin, Antimicrobial peptides and Degranulation.
The concepts of his Inflammation study are interwoven with issues in Chemotaxis and Pharmacology. In his research on the topic of Cathelicidin, Sepsis is strongly related with Lipopolysaccharide. His work focuses on many connections between Antimicrobial peptides and other disciplines, such as Innate immune system, that overlap with his field of interest in Microbiology.
His scientific interests lie mostly in Internal medicine, Endocrinology, Sepsis, Immunology and Glucosamine. In general Internal medicine study, his work on Adverse effect, Type II collagen and Chemotherapy often relates to the realm of Cartilage metabolism, thereby connecting several areas of interest. His studies in Sepsis integrate themes in fields like Antithrombin, Lipopolysaccharide, Microbiology, Microcirculation and Peptide.
His Glucosamine research incorporates elements of Synovial Cell, Athletes, Pharmacology and Cell biology. He combines subjects such as Inflammation and Phosphorylation with his study of Synovial Cell. Isao Nagaoka does research in Cell biology, focusing on Extracellular specifically.
Isao Nagaoka spends much of his time researching Immunology, Internal medicine, Lipopolysaccharide, Pharmacology and Endocrinology. His research integrates issues of Osteocalcin and Oncology in his study of Internal medicine. His Lipopolysaccharide study also includes fields such as
Isao Nagaoka has researched Proteases in several fields, including Inflammation and Cell biology. His biological study spans a wide range of topics, including Histone H3, Functional food, Glucosamine and MAPK/ERK pathway. His work in Endocrinology tackles topics such as Type II collagen which are related to areas like Anterior cruciate ligament and Matrix metalloproteinase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antimicrobial Peptides Human β-Defensins Stimulate Epidermal Keratinocyte Migration, Proliferation and Production of Proinflammatory Cytokines and Chemokines
François Niyonsaba;Hiroko Ushio;Nobuhiro Nakano;William Ng.
Journal of Investigative Dermatology (2007)
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis.
François Niyonsaba;Kazuhisa Iwabuchi;Akimasa Someya;Michimasa Hirata.
Immunology (2002)
Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells
François Niyonsaba;Akimasa Someya;Michimasa Hirata;Hideoki Ogawa.
European Journal of Immunology (2001)
mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats
Tsukasa Nakamura;Mitsumine Fukui;Isao Ebihara;Shiori Osada.
Diabetes (1993)
Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
Isao Nagaoka;Satoko Hirota;François Niyonsaba;Michimasa Hirata.
Journal of Immunology (2001)
Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophils
François Niyonsaba;Hideoki Ogawa;Isao Nagaoka.
Immunology (2004)
An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7
Isao Nagaoka;Hiroshi Tamura;Michimasa Hirata.
Journal of Immunology (2006)
Epithelial cell-derived human β-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway
François Niyonsaba;Kazuhisa Iwabuchi;Hiroshi Matsuda;Hideoki Ogawa.
International Immunology (2002)
The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes
François Niyonsaba;Hiroko Ushio;Isao Nagaoka;Ko Okumura.
Journal of Immunology (2005)
Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells
François Niyonsaba;Hiroko Ushio;Mutsuko Hara;Hidenori Yokoi.
Journal of Immunology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Juntendo University
Juntendo University
Juntendo University
Teikyo University
Juntendo University
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Juntendo University
Duke University
National Defense Medical College
Tokyo Institute of Technology
Sichuan University
National Research Council Canada
Huazhong University of Science and Technology
University of Pittsburgh
Goethe University Frankfurt
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
University of Michigan–Ann Arbor
University of Alabama at Birmingham
Federal University of Rio Grande do Sul
University of California, Los Angeles
National Institutes of Health
Ehime University
Yale University
University of Iowa
University of California, Berkeley